Arteris, Inc. (NASDAQ:AIP) Short Interest Up 15.6% in December

Arteris, Inc. (NASDAQ:AIP) was the target of a significant growth in short interest during the month of December. As of December 31st, there was short interest totalling 356,200 shares, a growth of 15.6% from the December 15th total of 308,100 shares. Based on an average daily trading volume, of 204,000 shares, the short-interest ratio is presently 1.7 days. Approximately 1.4% of the shares of the company are sold short.

Arteris Stock Performance

Arteris stock opened at $11.48 on Friday. The company’s 50-day moving average price is $9.68 and its two-hundred day moving average price is $8.32. Arteris has a 52 week low of $4.91 and a 52 week high of $12.64. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.16 and a quick ratio of 1.16.

Wall Street Analysts Forecast Growth

Separately, Rosenblatt Securities reaffirmed a “buy” rating and set a $15.00 target price on shares of Arteris in a research report on Wednesday, November 6th.

Insider Activity

In related news, CEO K Charles Janac sold 8,432 shares of the business’s stock in a transaction that occurred on Monday, January 6th. The stock was sold at an average price of $12.34, for a total transaction of $104,050.88. Following the transaction, the chief executive officer now directly owns 260,088 shares of the company’s stock, valued at approximately $3,209,485.92. The trade was a 3.14 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CFO Nicholas B. Hawkins sold 19,299 shares of the stock in a transaction that occurred on Wednesday, November 6th. The shares were sold at an average price of $8.14, for a total transaction of $157,093.86. Following the completion of the sale, the chief financial officer now directly owns 192,414 shares of the company’s stock, valued at $1,566,249.96. This trade represents a 9.12 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 325,456 shares of company stock valued at $3,355,352. Insiders own 33.70% of the company’s stock.

Institutional Trading of Arteris

Hedge funds have recently modified their holdings of the business. Needham Investment Management LLC raised its holdings in shares of Arteris by 14.7% during the 3rd quarter. Needham Investment Management LLC now owns 2,735,000 shares of the company’s stock valued at $21,114,000 after purchasing an additional 350,000 shares in the last quarter. Essex Investment Management Co. LLC acquired a new position in shares of Arteris during the 3rd quarter valued at about $2,504,000. Bank of New York Mellon Corp acquired a new position in Arteris during the second quarter valued at approximately $580,000. Jacobs Levy Equity Management Inc. grew its position in shares of Arteris by 36.3% in the third quarter. Jacobs Levy Equity Management Inc. now owns 253,211 shares of the company’s stock valued at $1,955,000 after purchasing an additional 67,414 shares during the last quarter. Finally, State Street Corp lifted its holdings in shares of Arteris by 18.5% during the 3rd quarter. State Street Corp now owns 410,578 shares of the company’s stock worth $3,170,000 after acquiring an additional 64,081 shares during the period. Hedge funds and other institutional investors own 64.36% of the company’s stock.

About Arteris

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.